Protein glycosylation is a ubiquitous post-translational modification that is involved in the regulation of many aspects of protein function. In order to uncover the biological roles of this modification, imaging the glycosylation state of specific proteins within living cells would be of fundamental importance. To date, however, this has not been achieved. Herein, we demonstrate protein-specific detection of the glycosylation of the intracellular proteins OGT, Foxo1, p53, and Akt1 in living cells. Our generally applicable approach relies on Diels-Alder chemistry to fluorescently label intracellular carbohydrates through metabolic engineering. The target proteins are tagged with enhanced green fluorescent protein (EGFP). Förster resonance energy transfer (FRET) between the EGFP and the glycan-anchored fluorophore is detected with high contrast even in presence of a large excess of acceptor fluorophores by fluorescence lifetime imaging microscopy (FLIM).

The lead compound of a new series of 3-pyridyl ethers, the azetidine derivative A-85380 (3-[(S)-2-azetidinylmethoxy]pyridine), is a potent and selective ligand for the human alpha4beta2 nicotinic acetylcholine receptor (nAChR) subtype. In vitro, the fluoro derivative of A-85380 (2-fluoro-3-[(S)-2-azetidinylmethoxy]pyridine or F-A-85380) competitively displaced [3H]cytisine or [3H]epibatidine with Ki values of 48 and 46 pM, respectively. F-A-85380 has been labeled with the positron emitter fluorine-18 (t1/2 (half-life) = 110 min) by no-carrier-added nucleophilic aromatic substitution by K[18F]F-K222 complex with (3-[2(S)-N-(tert-butoxycarbonyl)-2-azetidinylmethoxy]pyridin-2-yl) tri methylammonium trifluoromethanesulfonate as a highly efficient labeling precursor, followed by TFA removal of the Boc protective group. The total synthesis time was 50-53 min from the end of cyclotron fluorine-18 production (EOB). Radiochemical yields, with respect to initial [18F]fluoride ion radioactivity, were 68-72% (decay-corrected) and 49-52% (non-decay-corrected), and the specific radioactivities at EOB were 4-7 Ci/micromol (148-259 GBq/micromol). In vivo characterization of [18F]F-A-85380 showed promising properties for PET imaging of central nAChRs. This compound does not bind in vivo to alpha7 nicotinic or 5HT3 receptors. Moreover, its cerebral uptake can be modulated by the synaptic concentration of the endogenous ligand acetylcholine. The preliminary PET experiments in baboons with [18F]F-A-85380 show an accumulation of the radiotracer in the brain within 60 min. In the thalamus, a nAChR-rich area, uptake of radioactivity reached a maximum at 60 min (4% I.D./100 mL of tissue). [18F]F-A-85380 appears to be a suitable radioligand for brain imaging nAChRs with PET.

No abstract

Die Glycosylierung von Proteinen ist eine weit verbreitete posttranslationale Modifikation, die an der Regulation vieler Proteinfunktionen beteiligt ist. Um die biologischen Funktionen dieser Modifikation zu verstehen, wäre die Visualisierung des Glycosylierungszustandes spezifischer Proteine in lebenden Zellen von entscheidender Bedeutung. Bisher wurde dies noch nicht erreicht. Hier zeigen wir die Detektion proteinspezifischer Glycosylierung der intrazellulären Proteine OGT, Foxo1, p53 und Akt1 in lebenden Zellen. Unser breit anwendbarer Ansatz beruht auf der Fluoreszenzmarkierung intrazellulärer, metabolisch eingebauter Kohlenhydrate durch Diels‐Alder‐Chemie. Die gewählten Proteine sind mit grün fluoreszierendem Protein (EGFP) markiert. Fluoreszenzlebenszeitmikroskopie (FLIM) gestattet die Detektion von Förster‐Resonanzenergietransfer (FRET) zwischen EGFP und dem am Glycan gebundenen Fluorophor mit hohem Kontrast selbst in Gegenwart des großen Überschusses an Akzeptorfluorophor.